Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 6/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8097616 | 1.00 | SLC6A2 (0.48) | SLC6A2SLC6A4MTNR1BMTNR1ATRPV1 | |
| SCHEMBL8097820 | 0.86 | MTNR1B (0.43) | MTNR1BMTNR1ATRPV1 | |
| SCHEMBL8097822 | 0.86 | MTNR1B (0.43) | MTNR1BMTNR1ATRPV1 | |
| SCHEMBL8088925 | 0.79 | HTR2A (0.55) | MTNR1BMTNR1A | |
| SCHEMBL8089150 | 0.79 | HTR2A (0.55) | MTNR1BMTNR1A | |
| SCHEMBL8096202 | 0.79 | HTR2C (0.51) | SLC6A2SLC6A4MTNR1BMTNR1A | |
| SCHEMBL8096201 | 0.79 | HTR2C (0.51) | SLC6A2SLC6A4MTNR1BMTNR1A | |
| SCHEMBL27385861 | 0.76 | MTNR1B (0.56) | MTNR1BMTNR1A | |
| SCHEMBL8101397 | 0.75 | HTR2C (0.55) | MTNR1BMTNR1A | |
| SCHEMBL8101400 | 0.75 | HTR2C (0.55) | MTNR1BMTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0747346-B1 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL MYERS SQUIBB CO (US) | 2000-02-16 | — | — | EP | claimed |
| EP-0747346-A2 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | claimed |
| EP-0747346-B1 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL MYERS SQUIBB CO (US) | 2000-02-16 | — | — | EP | disclosed |
| EP-0747346-A2 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |